Bionomics Management

Management criteria checks 1/4

Bionomics' CEO is Spyros Papapetropoulos, appointed in Jan 2023, has a tenure of 1.83 years. total yearly compensation is $905.47K, comprised of 61.3% salary and 38.7% bonuses, including company stock and options. directly owns 0.19% of the company’s shares, worth €8.97K. The average tenure of the management team and the board of directors is 1.3 years and 3.2 years respectively.

Key information

Spyros Papapetropoulos

Chief executive officer

US$905.5k

Total compensation

CEO salary percentage61.3%
CEO tenure1.8yrs
CEO ownership0.2%
Management average tenure1.3yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Spyros Papapetropoulos's remuneration changed compared to Bionomics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$11m

Jun 30 2024US$905kUS$555k

-US$15m

Mar 31 2024n/an/a

-US$18m

Dec 31 2023n/an/a

-US$21m

Sep 30 2023n/an/a

-US$20m

Jun 30 2023US$616kUS$321k

-US$21m

Compensation vs Market: Spyros's total compensation ($USD905.47K) is above average for companies of similar size in the German market ($USD474.67K).

Compensation vs Earnings: Spyros's compensation has increased whilst the company is unprofitable.


CEO

Spyros Papapetropoulos (51 yo)

1.8yrs

Tenure

US$905,469

Compensation

Dr. Spyridon Papapetropoulos, M. D., Ph. D., also known as Spyros, serves as Director, President & Chief Executive Officer at Bionomics Limited from January 05, 2023. He served as Member of Scientific Advi...


Leadership Team

NamePositionTenureCompensationOwnership
Spyridon Papapetropoulos
CEO, President & Director1.8yrsUS$905.47k0.19%
€ 9.0k
Timothy Cunningham
Chief Financial Officer1.3yrsno datano data
Elizabeth Doolin
Senior Vice President of Clinical Developmentless than a yearUS$237.80k0.0041%
€ 190.4
Julie Kerner
Senior Vice President of Business Operations1.5yrsno datano data
Mark Smith
Chief Medical Officerno datano datano data
Adrian Hinton
Financial Controller1.3yrsUS$199.52k0%
€ 0
Rajeev Chandra
Company Secretaryno datano datano data

1.3yrs

Average Tenure

61yo

Average Age

Experienced Management: B1N0's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Spyridon Papapetropoulos
CEO, President & Director1.8yrsUS$905.47k0.19%
€ 9.0k
David Wilson
Independent Non-Executive Director8.4yrsUS$38.06k0.0081%
€ 376.2
Alan Fisher
Independent Non-Executive Chair of the Board8.2yrsUS$59.07k0.0032%
€ 149.3
Jane Ryan
Independent Non-Executive Director4.1yrsUS$36.25k0%
€ 0
Srinivas Rao
Member of Clinical Advisory Board3.1yrsUS$43.30kno data
John Krystal
Member of Clinical Advisory Board3.1yrsno datano data
Murray Stein
Member of Clinical Advisory Boardno datano datano data
Peter Miles Davies
Independent Non-Executive Director3.3yrsUS$33.69k0.0087%
€ 403.1
Michael Gendreau
Member of Clinical Advisory Board3.1yrsno datano data

3.2yrs

Average Tenure

57.5yo

Average Age

Experienced Board: B1N0's board of directors are considered experienced (3.2 years average tenure).